What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Platelet
- Antibody
Richard H. Aster focuses on Platelet, Immunology, Antibody, Internal medicine and Molecular biology.
His research in Platelet is mostly focused on Platelet factor 4.
His Immunology research focuses on Drug and how it connects with Drug-induced immune thrombocytopenia.
His Antibody research is multidisciplinary, incorporating elements of Complication and Granulocyte.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
His studies deal with areas such as Sequence analysis, Biochemistry, Complementary DNA, Oligonucleotide and Polymerase chain reaction as well as Molecular biology.
His most cited work include:
- Platelet Sequestration in Man. I. Methods (717 citations)
- Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. (665 citations)
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. (483 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Platelet, Immunology, Antibody, Antigen and Molecular biology.
His Platelet research is multidisciplinary, incorporating perspectives in Heparin, Biochemistry and Glycoprotein.
His Heparin study integrates concerns from other disciplines, such as Anticoagulant and Thrombosis.
As part of his studies on Immunology, Richard H. Aster frequently links adjacent subjects like Neonatal alloimmune thrombocytopenia.
His Antibody research incorporates elements of Platelet membrane glycoprotein and Drug.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
He most often published in these fields:
- Platelet (69.35%)
- Immunology (67.74%)
- Antibody (47.47%)
What were the highlights of his more recent work (between 2008-2021)?
- Immunology (67.74%)
- Antibody (47.47%)
- Platelet (69.35%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Antibody, Platelet, Heparin and Platelet factor 4.
His Immunology study which covers Drug that intersects with Immune thrombocytopenia and Pathogenesis.
His work deals with themes such as Molecular biology, Lung injury and Pharmacology, which intersect with Antibody.
The subject of his Platelet research is within the realm of Internal medicine.
His Heparin study deals with Area under the curve intersecting with Gold standard.
His work in Platelet factor 4 tackles topics such as Heparin-induced thrombocytopenia which are related to areas like Pediatrics.
Between 2008 and 2021, his most popular works were:
- Drug‐induced immune thrombocytopenia: pathogenesis, diagnosis, and management (212 citations)
- Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. (210 citations)
- Drug-induced thrombocytopenia: pathogenesis, evaluation, and management (146 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibody
- Platelet
Richard H. Aster spends much of his time researching Immunology, Antibody, Platelet, Heparin-induced thrombocytopenia and Heparin.
His biological study spans a wide range of topics, including Cancer research and Drug.
His Antibody research integrates issues from Molecular biology, Lung injury, Pathogenesis and Antigen.
His biological study deals with issues like In vivo, which deal with fields such as Hemolytic anemia.
The Heparin-induced thrombocytopenia study combines topics in areas such as Pediatrics and Intensive care medicine.
His work in Heparin addresses subjects such as Immunoglobulin G, which are connected to disciplines such as P-selectin, Potency and Serology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
